Lewes, DE -- (SBWIRE) -- 11/03/2016 -- Hypersensitivity Hypersensitivity refers to is a reaction which occurs soon after exposure to allergens. Hypersensitivity diseases have been grouped into four major categories immediate (type I) hypersensitivity, antibody-mediated (type II) hypersensitivity, immune complex-mediated (type III) hypersensitivity and cell-mediated (type IV) hypersensitivity. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. Treatment includes adrenaline (epinephrine), antihistamines, and corticosteroids.

Hypersensitivity pipeline therapeutics constitutes close to 138 molecules. Out of which approximately 122 molecules are developed by Companies and remaining by the Universities/Institutes. The molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 4, 1, 7, 15, 13, 56, 21 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 4, 1, 9 and 2 molecules, respectively.

Hypersensitivity – Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Hypersensitivity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Hypersensitivity and features dormant and discontinued projects.

The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

For more information Visit at: http://www.marketresearchreports.com/global-markets-direct/hypersensitivity-pipeline-review-h2-2016

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions